OPNT Share Price Performance
US$0
0.00 (0.00%)
Price US$0
Share Pricen/a
Opiant Pharmaceuticals, Inc. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
OPNT Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
Opiant Pharmaceuticals, Inc. Key Details
Last Reported Earnings
Sep 30, 2022
Next Reporting Earnings
n/a
- -6.28
- -31.85%
- -148.12%
- 67.1%
About OPNT
- Founded
- 2005
- Employees
- 38
- CEO
- WebsiteView website
Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company, develops medicines for addictions and drug overdose. The company offers NARCAN nasal spray, a treatment to reverse opioid overdoses. Its pipeline of product candidates includes medicines for the treatment for opioid overdose reversal; alcohol use disorders; acute cannabinoid overdose; and opioid use disorders. The company was formerly known as Lightlake Therapeutics Inc. and changed its name to Opiant Pharmaceuticals, Inc. in January 2016. Opiant Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Santa Monica, California.
